Review
doi: 10.1097/CEJ.0b013e3282f75e5d.
Lobular carcinoma in situ
Affiliations
- PMID: 18562954
- DOI: 10.1097/CEJ.0b013e3282f75e5d
Item in Clipboard
Review
Lobular carcinoma in situ
Eur J Cancer Prev.
2008 Aug.
Abstract
The diagnosis of lobular carcinoma in situ (LCIS) provokes considerable anxiety in patients owing to misconceptions about this diagnosis. Initially LCIS was considered a premalignant lesion, but it is now a marker of increased risk. The number of women diagnosed with LCIS has increased in recent years most likely owing to more rigorous breast cancer screening. Implications of this diagnosis and management options are discussed in this review.
Similar articles
-
Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.Cancer. 2006 May 15;106(10):2104-12. doi: 10.1002/cncr.21864. Cancer. 2006. PMID: 16604564
-
Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.Cancer. 2006 Jan 1;106(1):42-50. doi: 10.1002/cncr.21571. Cancer. 2006. PMID: 16333852
-
Risk counseling and management in patients with lobular carcinoma in situ.Am J Surg. 2005 May;189(5):610-4; discussion 614-5. doi: 10.1016/j.amjsurg.2005.01.032. Am J Surg. 2005. PMID: 15862506
-
Management of in situ carcinoma of the breast: lobular and ductal origin.R I Med. 1995 Sep;78(9):242-5. R I Med. 1995. PMID: 7579718 Review. No abstract available.
-
Lobular carcinoma in situ (LCIS): pathology and treatment.J Cell Biochem Suppl. 1993;17G:53-8. J Cell Biochem Suppl. 1993. PMID: 8007710 Review.
Cited by
-
Quantitative expression of MMPs 2, 9, 14, and collagen IV in LCIS and paired normal breast tissue.Sci Rep. 2019 Sep 17;9(1):13432. doi: 10.1038/s41598-019-48602-6. Sci Rep. 2019. PMID: 31530842 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
